CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in TRVI — Trevi Therapeutics, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in TRVI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$18,004,747
+$7,976,724 QoQ
Shares Held
965,402
+14.9% QoQ
Ownership
0.678%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#44
of 216 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. TRVI ranks #76 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in TRVI
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,004,747 | 965,402 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $10,028,023 | 840,572 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $10,476,736 | 836,800 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $7,377,928 | 806,331 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,235,864 | 225,935 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,305,288 | 207,518 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $713,019 | 173,063 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $504,066 | 150,918 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $449,735 | 150,918 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $371,589 | 107,707 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $144,327 | 107,707 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $234,801 | 107,707 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $257,419 | 107,707 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $23,230 | 12,557 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $24,235 | 12,557 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $19,337 | 12,557 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $35,285 | 12,557 | Shares | Sole | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||